Search for stock quotes, financial statistics and more
It may not have the buzz of biotech or the cachet of cannabis but the medical device space is defini... Read More
Research Capital Corporation analyst Andre Uddin is maintaining his “Hold” rating on Pr... Read More
Ahead of second quarter earnings being released next week, Raymond James analyst Rahul Sarugaser bel... Read More
The path is looking clearer for Profound Medical’s (Profound Medical Stock Quote, Chart, News TSX:... Read More
Based on a stronger outlook for its TULSA-PRO medical device, Raymond James analyst Rahul Sarugaser ... Read More
Share
